To fund clinical trials of its prescription-only, smartphone-based treatments for Type 2 diabetes, high blood pressure and more, Better Therapeutics is going public through a deal with a special purpose acquisition company.
In a long-term collaboration that is, fittingly, the exact opposite of shortsighted, Johnson & Johnson Vision has partnered with the Japanese contact lens manufacturer Menicon to slow the progression of childhood myopia on a global scale.
Donisi scores FDA clearance for contactless AI system that spots changes in heart, breathing patterns
It goes against all medical knowledge and basic common sense to say vital signs are only skin deep, but that’s exactly the case for a newly FDA-cleared platform that can detect shifts in cardiac and pulmonary performance from afar.
After breathing through an implanted tube in her throat for six years, a woman underwent the first successful human trachea transplant, in an 18-hour procedure performed by surgeons at Mount Sinai.
Pear Therapeutics is building out its app-based digital treatment platform into something a little more tangible.
Rare, incurable conditions call for the most innovative treatments—and that’s exactly the approach the National Institutes of Health is taking to develop a new test for patients with methylmalonic acidemia, or MMA.
After nabbing $230 million at the start of the year, “gene writing” biotech Tessera Therapeutics has boosted its management and research team, including poaching bluebird bio’s chief medical officer.
The FDA didn’t need 3D glasses to see the potential benefits of Philips’ new three-dimensional imaging software, as evidenced by the 510(k) clearance the agency recently granted to its SmartCT program.
Coming off what it’s described as its “best year ever,” the continuous glucose monitoring provider Dexcom is now looking to expand its work among people with Type 2 diabetes in a new, wider collaboration with Welldoc and its digital health platforms.
AstraZeneca, MGH test virtual health platform to keep prescribing up—even when in-person doc visits are down
With the past year of the COVID-19 pandemic pushing more people toward virtual doctor visits, AstraZeneca is preparing for it to become the new normal through a new project with Massachusetts General Hospital.